Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant TIP for Penile Squamous Cell Carcinoma
NCT00512096Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 1999
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, ifosfamide, cisplatin in penile squamous cell carcinoma (PSCC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 1999; status: completed.
02
Drugs
paclitaxelifosfamidecisplatin
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on NCT00512096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512096.